Northern Trust’s La Jolla Pharmaceutical Company LJPC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-80,615
| Closed | -$257K | – | 4834 |
|
|
2022
Q2 | $257K | Buy |
80,615
+562
| +0.7% | +$2.19K | ﹤0.01% | 3789 |
|
|
2022
Q1 | $341K | Buy |
80,053
+4,047
| +5% | +$17.6K | ﹤0.01% | 3886 |
|
|
2021
Q4 | $353K | Sell |
76,006
-1,833
| -2% | -$7.64K | ﹤0.01% | 3944 |
|
|
2021
Q3 | $311K | Buy |
77,839
+3,527
| +5% | +$14K | ﹤0.01% | 3961 |
|
|
2021
Q2 | $318K | Sell |
74,312
-153,776
| -67% | -$659K | ﹤0.01% | 3910 |
|
|
2021
Q1 | $967K | Sell |
228,088
-22,339
| -9% | -$123K | ﹤0.01% | 3600 |
|
|
2020
Q4 | $972K | Sell |
250,427
-23,521
| -9% | -$101K | ﹤0.01% | 3531 |
|
|
2020
Q3 | $1.1M | Sell |
273,948
-48,020
| -15% | -$199K | ﹤0.01% | 3356 |
|
|
2020
Q2 | $1.37M | Buy |
321,968
+23,683
| +8% | +$144K | ﹤0.01% | 3231 |
|
|
2020
Q1 | $1.25M | Buy |
298,285
+222
| +0.1% | +$1.4K | ﹤0.01% | 3111 |
|
|
2019
Q4 | $1.17M | Sell |
298,063
-1,826
| -0.6% | -$10.8K | ﹤0.01% | 3342 |
|
|
2019
Q3 | $2.64M | Buy |
299,889
+23,735
| +9% | +$224K | ﹤0.01% | 2934 |
|
|
2019
Q2 | $2.56M | Buy |
276,154
+1,880
| +0.7% | +$14.2K | ﹤0.01% | 2935 |
|
|
2019
Q1 | $1.76M | Sell |
274,274
-23,619
| -8% | -$154K | ﹤0.01% | 3155 |
|
|
2018
Q4 | $2.81M | Sell |
297,893
-6,333
| -2% | -$95.3K | ﹤0.01% | 2865 |
|
|
2018
Q3 | $6.13M | Buy |
304,226
+5,343
| +2% | +$140K | ﹤0.01% | 2576 |
|
|
2018
Q2 | $8.72M | Buy |
298,883
+48,382
| +19% | +$1.49M | ﹤0.01% | 2358 |
|
|
2018
Q1 | $7.46M | Sell |
250,501
-692
| -0.3% | -$22.3K | ﹤0.01% | 2361 |
|
|
2017
Q4 | $8.08M | Sell |
251,193
-651
| -0.3% | -$21.3K | ﹤0.01% | 2332 |
|
|
2017
Q3 | $8.76M | Sell |
251,844
-4,796
| -2% | -$154K | ﹤0.01% | 2287 |
|
|
2017
Q2 | $7.64M | Buy |
256,640
+53,678
| +26% | +$1.54M | ﹤0.01% | 2340 |
|
|
2017
Q1 | $6.06M | Buy |
202,962
+5,542
| +3% | +$141K | ﹤0.01% | 2441 |
|
|
2016
Q4 | $3.46M | Buy |
197,420
+10,448
| +6% | +$200K | ﹤0.01% | 2784 |
|
|
2016
Q3 | $4.45M | Sell |
186,972
-2,611
| -1% | -$49.2K | ﹤0.01% | 2584 |
|
|
2016
Q2 | $3.03M | Buy |
189,583
+19,293
| +11% | +$346K | ﹤0.01% | 2799 |
|
|
2016
Q1 | $3.56M | Buy |
170,290
+2,882
| +2% | +$51.4K | ﹤0.01% | 2636 |
|
|
2015
Q4 | $4.52M | Buy |
167,408
+26,189
| +19% | +$714K | ﹤0.01% | 2517 |
|
|
2015
Q3 | $3.92M | Buy |
141,219
+100,450
| +246% | +$3.17M | ﹤0.01% | 2591 |
|
|
2015
Q2 | $999K | Buy |
40,769
+18,644
| +84% | +$384K | ﹤0.01% | 3347 |
|
|
2015
Q1 | $405K | Buy |
22,125
+5,800
| +36% | +$118K | ﹤0.01% | 3667 |
|
|
2014
Q4 | $301K | Buy |
16,325
+1,412
| +9% | +$16.8K | ﹤0.01% | 3693 |
|
|
2014
Q3 | $143K | Buy |
+14,913
| New | +$148K | ﹤0.01% | 3938 |
|
Northern Trust's LJPC Position: Q3 2022 in Review
Northern Trust sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 80,615 shares — an estimated $257K sold.
Northern Trust first reported a position in LJPC in Q3 2014 and held it in 32 quarters. The position peaked at $8.76M in Q3 2017. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.
- Northern Trust reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
- Northern Trust sold 80,615 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $257K.
- Northern Trust first reported a position in La Jolla Pharmaceutical Company in Q3 2014 and held it in 32 quarters.
- Northern Trust's La Jolla Pharmaceutical Company position peaked at $8.76M in Q3 2017.
- 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.
Based on Northern Trust's 13F filing for Q3 2022, filed 14 Nov 2022.